Skip to main content
Marine snails and slugs: a great place to look for antiviral drugs
Journal of Virology
  • Vinh T Dang, Flinders University
  • Kirsten Benkendorff, Dr, Southern Cross University
  • Tim Green, Macquarie University
  • Peter Speck, Flinders University
Document Type
Publication Date
Peer Reviewed
Molluscs, one of the most successful phyla, lack clear evidence of adaptive immunity, yet thrive in the oceans, which are rich in viruses. There are thought to be nearly 120,000 species of Mollusca, most living in marine habitats. Despite the extraordinary abundance of viruses in oceans, molluscs often have very long lifespans (10-100s yrs). Thus, their innate immunity must be highly effective at countering viral infections. Antiviral compounds are a crucial component of molluscan defenses against viruses, and have diverse mechanisms of action against a wide variety of viruses, including many that are human pathogens. Antiviral compounds found in abalone, oyster, mussels and other cultured molluscs are available in large supply, providing good opportunities for future research and development. However, most members of the phylum Mollusca have not been examined for the presence of antiviral compounds. The enormous diversity and adaptations of molluscs implies a potential source of novel antiviral compounds for future drug discovery.
Citation Information

Dang, VT, Benkendorff, K, Green, T & Speck, P 2015, 'Marine snails and slugs: a great place to look for antiviral drugs', Journal of Virology.

Article available on Open Access